发明公开
- 专利标题： NR1H4 NUCLEAR RECEPTOR BINDING COMPOUNDS
- 专利标题（中）： NR1H4，核受体结合的化合物
-
申请号： EP02750474.5申请日： 2002-08-13
-
公开(公告)号： EP1423113A1公开(公告)日： 2004-06-02
- 发明人: BAUER, Ulrike , CHERUVALLATH, Zach , DEUSCHLE, Ulrich , DNEPROVSKAIA, Elena , GAHMAN, Tim , GIEGRICH, Kristina , HANECAK, Ronnie , HEBERT, Normand , KIELY, John , KOBER, Ingo , KOGL, Manfred , KRANZ, Harald , KREMOSER, Claus , LEE, Matthew , OTTE, Kerstin , SAGE, Carlton , SUD, Manish
- 申请人： LION bioscience AG
- 申请人地址： Waldhofer Strasse 98 69123 Heidelberg DE
- 专利权人： LION bioscience AG
- 当前专利权人： LION bioscience AG
- 当前专利权人地址： Waldhofer Strasse 98 69123 Heidelberg DE
- 代理机构： Krauss, Jan
- 优先权： EP01119473 20010813; US185731 20020701
- 国际公布： WO2003015777 20030227
- 主分类号： A61K31/426
- IPC分类号： A61K31/426 ; C07D277/40 ; C07D277/42 ; C07D277/44 ; C07D277/46
摘要：
The present invention relates to compounds according to the general formula (I) which bind to the NR1H4 receptor and act as agonists of the NR1H4 receptor. The invention further relates to the treatment of diseases and/or conditions through binding of the nuclear receptor by the compounds and the production of medicaments using the compounds.
信息查询
IPC分类:
